Amparo Alba-Redondo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Amparo Alba-Redondo has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Begoña Laiz-Marro
Laboratory Department Hospital Universitari i Politècnic La Fe Valencia Spain
1 shared publication - Belén Beltrán
Servicio de Urología, Hospital Clínico Universitario Lozano Blesa, Zaragoza, España
1 shared publication - Carmen Lloret-Sos
Microbiology Department, Hospital Univeritari i Politècnic la Fe. Av Fernando Abril Martorell 106; 46026 València, Spain
1 shared publication - Cristina Aguado Codina
Clinical Laboratory Unit, La Fe University Hospital, Valencia, Spain
1 shared publication - Esteban Sáez-González
Inflammatory Bowel Disease Unit, Gastroenterology Department, La Fe University and Polytechnic Hospital, Valencia, Spain
1 shared publication - Jordi Tortosa-Carreres
Laboratory Department , Hospital Universitari i Politècnic La Fe , Valencia , Spain
1 shared publication
Latest Publications
- 24 December 2023
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 108 (3) , 116167
Evaluating the diagnostic performance of Liaison® chemiluminescence assay as screening tool for detection of acute Epstein-Barr infection: A comparative study
- 24 December 2023
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 108 (3) , 116167
Evaluating the diagnostic performance of Liaison® chemiluminescence assay as screening tool for detection of acute Epstein-Barr infection: A comparative study
- Open Access
Influence of Vitamin D Deficiency on Inflammatory Markers and Clinical Disease Activity in IBD Patients
Vitamin D has recently been discovered to be a potential immune modulator. Low serum vitamin D levels have been associated with risk of relapse and exacerbation of clinical outcomes in Crohn’s disease (CD) and ulcerative colitis (UC). A retrospective, longitudinal study was conducted to determine the association between vitamin D levels and inflammatory markers and clinical disease activity in inflammatory bowel disease (IBD). In addition, circulating 25(OH)D3 progression was evaluated according to vitamin D supplementation. Participants were separated into three groups according to their vitamin D level: severe deficiency (SD), moderate deficiency (MD) and sufficiency (S). Serum 25(OH)D3 was inversely correlated with faecal calprotectin (FC) for CD and UC but was only correlated with C-reactive protein (CRP) for UC patients. In the multivariate analysis of FC, CRP and fibrinogen (FBG), we predicted the presence of a patient in the SD group with 80% accuracy. A deficiency of 25(OH)D3 was associated with increased hospitalisations, flare-ups, the use of steroids and escalating treatment. Supplemental doses of vitamin D were likely to be insufficient to reach adequate serum levels of 25(OH)D3. Vitamin D intervention studies are warranted to determine whether giving higher doses of vitamin D in IBD might reduce intestinal inflammation or disease activity.
Open AccessInfluence of Vitamin D Deficiency on Inflammatory Markers and Clinical Disease Activity in IBD Patients
Vitamin D has recently been discovered to be a potential immune modulator. Low serum vitamin D levels have been associated with risk of relapse and exacerbation of clinical outcomes in Crohn’s disease (CD) and ulcerative colitis (UC). A retrospective, longitudinal study was conducted to determine the association between vitamin D levels and inflammatory markers and clinical disease activity in inflammatory bowel disease (IBD). In addition, circulating 25(OH)D3 progression was evaluated according to vitamin D supplementation. Participants were separated into three groups according to their vitamin D level: severe deficiency (SD), moderate deficiency (MD) and sufficiency (S). Serum 25(OH)D3 was inversely correlated with faecal calprotectin (FC) for CD and UC but was only correlated with C-reactive protein (CRP) for UC patients. In the multivariate analysis of FC, CRP and fibrinogen (FBG), we predicted the presence of a patient in the SD group with 80% accuracy. A deficiency of 25(OH)D3 was associated with increased hospitalisations, flare-ups, the use of steroids and escalating treatment. Supplemental doses of vitamin D were likely to be insufficient to reach adequate serum levels of 25(OH)D3. Vitamin D intervention studies are warranted to determine whether giving higher doses of vitamin D in IBD might reduce intestinal inflammation or disease activity.